Colorectal Adenocarcinoma clinical trials

Explore recruiting colorectal adenocarcinoma clinical trials.

Recruiting colorectal adenocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Colorectal Adenocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label, Multicenter, First-in-Human, Phase 1 Dose Escalation and Multicohort Expansion Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors, Including Sarcomas.

France, Italy, Netherlands, Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Hepatic arterial infusion PUMP chemotherapy combined with systemIc chemoTherapy for potentially resectable colorectal liver metastases. - The PUMP-IT study (M19PIT)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

A phase I/IIa safety, dose finding and feasibility trial of CD30/CEA CART in patients with liver metastases from CEA positive colorectal adenocarcinoma

Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

BEvacizumab plus Trifluridine/tipiracil in a bi-WEEkly administration to reduce grade 3-4 Neutropenia in patients with mCRC: A prospective, multicenter, comparative, randomized GERCOR G-124 BETWEEN phase II study

France

Therapeutic exploratory (Phase II) EU CTIS Study details

ENCORAFENIB+CETUXIMAB BEYOND PROGRESSION IN COMBINATION WITH FOLFIRI IN PATIENTS WITH BRAF V600E MUTATED METASTATIC COLORECTAL CANCER PROGRESSING ON ENCORAFENIB + CETUXIMAB

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A study to learn more about how safe BAY 3771249 is and how well it works in people with advanced or metastatic colorectal cancer that has a KRAS G12D mutation

Finland, Spain, Sweden, Italy, Denmark, Netherlands +1 more

Human Pharmacology (Phase I)- Other EU CTIS Study details

Colorectal Adenocarcinoma trials by city

Colorectal Adenocarcinoma in Toronto Colorectal Adenocarcinoma in Vancouver Colorectal Adenocarcinoma in Montreal Colorectal Adenocarcinoma in Calgary Colorectal Adenocarcinoma in Edmonton Colorectal Adenocarcinoma in Ottawa Colorectal Adenocarcinoma in Winnipeg Colorectal Adenocarcinoma in Quebec City Colorectal Adenocarcinoma in Hamilton Colorectal Adenocarcinoma in Kitchener Colorectal Adenocarcinoma in London Colorectal Adenocarcinoma in Halifax Colorectal Adenocarcinoma in New York Colorectal Adenocarcinoma in Los Angeles Colorectal Adenocarcinoma in Chicago Colorectal Adenocarcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease